[Function and gene expression of the active efflux transporters in drug-resistant Candida albicans]

Hui-Jun Guo1, Zhong-di Xia, Gao-Li Wu

  • 1Department of Microbiology, Xiangya School of Medicine, Central South University, Changsha 410078, China.

Abstract

Insights

Active efflux pumps in Candida albicans contribute to fluconazole resistance. Measuring Rhodamine 6G efflux can identify resistant strains overexpressing efflux pump genes like CDR1 and CDR2.

Area of Science:

  • Mycology
  • Molecular Biology
  • Antimicrobial Resistance

Background:

  • Candida albicans is a common fungal pathogen.
  • Antifungal drug resistance, particularly to fluconazole, is a growing clinical concern.
  • Efflux pumps play a role in mediating drug resistance in various microorganisms.

Purpose of the Study:

  • To investigate the role of active efflux transporters in fluconazole-resistant Candida albicans.
  • To examine the gene expression of key efflux pump genes (CDR1 and CDR2).
  • To evaluate Rhodamine 6G efflux as a marker for drug resistance.

Main Methods:

  • Broth microdilution was used to determine minimal inhibitory concentrations (MICs) of antifungals.
  • Rhodamine 6G efflux was compared between sensitive and fluconazole-resistant C. albicans strains.
  • Reverse transcriptase-polymerase chain reaction (RT-PCR) quantified mRNA levels of CDR1 and CDR2.

Main Results:

  • Some fluconazole-resistant strains showed significantly increased Rhodamine 6G efflux, especially with glucose.
  • Gene expression of CDR1 and CDR2 was markedly elevated in these resistant strains compared to sensitive ones.
  • A correlation was observed between increased efflux and higher gene expression of CDR1 and CDR2.

Conclusions:

  • Overexpression of active efflux pump genes, such as CDR1 and CDR2, is associated with fluconazole resistance in Candida albicans.
  • Rhodamine 6G efflux measurement is a viable method for identifying C. albicans strains with resistance mediated by excessive efflux pump expression.

Related Concept Videos

Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport01:19

Drug Absorption Mechanism: Carrier-Mediated Membrane Transport

Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Active Transport01:14

Active Transport

Active transport is a critical biological process that allows cells to move solutes against an electrochemical gradient. This process requires direct energy input and is characterized by its selectivity, saturability, and susceptibility to competitive inhibition.
Primary active transporters, like Na+, K+ and -ATPase, directly utilize ATP to move ions across the membrane. These transporters play significant roles in various physiological processes. For instance, Na+, K+ and -ATPase maintain...
Membrane Transporters01:31

Membrane Transporters

Transporters are essential membrane transport proteins with functions related to cell nutrition, homeostasis, communication, etc. Approximately 7% of all genes in the human genome code for transporters or transporter-related proteins.
Transporters are mainly composed of alpha-helices, built from bundles of ten or more helices traversing the plasma membrane. The solute-binding sites are located midway, where some of the helices are broken or distorted, making space for the binding site through...